It was observed that the liver Enpp1 expression were lower in MAFLD patients and MAFLD mouse models, whereas the Enpp1 deficient MAFLD mice exhibited enhanced obesity, insulin resistance and hepatic steatosis. This evidence concerns the gene ENPP1 and fatty liver disease.